Is Lasmiditan Succinate Tablet (Reyvow) in shortage?
No. Lasmiditan Succinate Tablet is no longer on FDA’s drug shortage list (last listed Nov 3, 2026).
No longer on FDA’s list (6)
These packages were on FDA’s shortage list and have since been removed (last seen Nov 3, 2026). Removal usually means supply recovered.
- Reyvow, Tablet, 50 mg (NDC 0002-4312-08)
- Reyvow, Tablet, 50 mg (NDC 0002-4312-61)
- Reyvow, Tablet, 50 mg (NDC 0002-4312-62)
- Reyvow, Tablet, 100 mg (NDC 0002-4491-08)
- Reyvow, Tablet, 100 mg (NDC 0002-4491-61)
- Reyvow, Tablet, 100 mg (NDC 0002-4491-62)
Lasmiditan Succinate Tablet shortage questions
Is Lasmiditan Succinate Tablet (Reyvow) in shortage?
No. Lasmiditan Succinate Tablet is no longer on FDA’s drug shortage list (last listed Nov 3, 2026).
What should I do if I can’t get Lasmiditan Succinate Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.